ADM
36
2
KHC
29
2
GIS
54
2
V
66
-4
AIV
60
3
MRK
66
3
PBI
30
7
MHK
40
-6
PDCO
57
2
NWL
32
4
CF
38
-3
IPG
42
-2
MCD
46
4
ECL
84
14
PRU
50
2
VZ
25
-2
COST
69
-4
HAS
49
3
AIZ
64
-2
SO
70
-3
ADM
36
2
KHC
29
2
GIS
54
2
V
66
-4
AIV
60
3
MRK
66
3
PBI
30
7
MHK
40
-6
PDCO
57
2
NWL
32
4
CF
38
-3
IPG
42
-2
MCD
46
4
ECL
84
14
PRU
50
2
VZ
25
-2
COST
69
-4
HAS
49
3
AIZ
64
-2
SO
70
-3
Financhill
Back

Larimar Therapeutics Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
72

LRMR
Larimar Therapeutics

Last Price:
7.29
Seasonality Move:
11.52%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.45
Seasonality Move:
3.65%
Buy
72
Larimar Therapeutics (LRMR) is a Buy

Is Larimar Therapeutics a Buy, Sell or Hold?

  • The current Larimar Therapeutics [LRMR] share price is $8.12. The Score for LRMR is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
  • LRMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LRMR Stock Price Chart

What is Larimar Therapeutics's stock price today?

  • The Larimar Therapeutics share price today is $8.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LRMR is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

LRMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.14 Buy
Relative Strength Index (14 RSI): 47.25 Sell
Chaikin Money Flow: 360857 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.34 - 9.36) Sell
Bollinger Bands (100): (6.53 - 10.17) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

LRMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.7 Sell
20-day SMA: 8.55 Sell
50-day SMA: 7.76 Buy
200-day SMA: 6.04 Buy
8-day EMA: 8.43 Sell
20-day EMA: 8.48 Sell
50-day EMA: 8.13 Sell
200-day EMA: 6.66 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Larimar Therapeutics Earnings Growth & LRMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.08 per share, a decrease this year of $0.57 per share, and a decrease next year of $0.38 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Larimar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):